(ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION (EIN 262890160) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

JAMES CARROLL

Phone

8332276773

Tax Period

2024-01-01 to 2024-12-31

(ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION, founded in 2008, is a small nonprofit in the Diseases & Disorders sector that reported $764K in total revenue in fiscal year 2024. Revenue surged 29% from the prior year, signaling strong growth momentum. The organization ran a surplus of $158K, a strong 21% operating margin.

Mission

TO FUND AND SUPPORT PROMISING RESEARCH TO FIND A CURE FOR PSEUDOMYXOMA PERITONEI (PMP),APPENDIX CANCER, AND RELATED PERITONEAL SURFACE MALIGNANCIES (PSM), AND TO FUND EDUCATIONAL PROGRAMS FOR PHYSICIANS AND PATIENTS ABOUT THESE DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $672,350

Program Service Revenue $0

Investment Income $101,155

Other Revenue $-9,697

TOTAL REVENUE $763,808

Expense Breakdown

Grants Paid $288,000

Salaries & Benefits $125,995

Fundraising Expenses $88,832

Program Expenses $451,211

Other Expenses $176,666

TOTAL EXPENSES $605,626

Year-over-Year Comparison

	2024	2023	Change
Revenue	$763,808	$591,795	+0.3%
Expenses	$605,626	$238,992	+1.5%
Net Income	$158,182	$352,803	-0.6%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES CARROLL	PRESIDENT	15.00	Officer Director	$0	$0	$0
JUDITH CULBERTSON	TREAS/VP	10.00	Officer Director	$0	$0	$0
DEBORAH SHELTON	SECY/EXEC DI	30.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$763,808	$605,626	$2,218,027	$158,182
2023	$591,795	$238,992	$2,054,563	$352,803
2022	$467,148	$228,028	$1,699,668	$239,120
2021	$864,315	$158,294	$1,467,493	$706,021
2020	$391,196	$265,909	$756,554	$125,287
2019	$306,812	$241,250	$629,240	$65,562
2018	$383,708	$203,894	$563,678	$179,814

(ACPMP)APPENDIX CANCERPSEUDOMYXOMA PERITONEI RESEARCH FOUNDATION